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AbstrAct
Introduction Living donation accounts for over one-
third of all kidney transplants taking place in the 
UK.1 The concept of anonymously donating a kidney 
to a stranger (non-directed altruistic or unspecified 
kidney donation (UKD)) remains uncomfortable for 
some clinicians, principally due to concerns about the 
motivations and long-term physical and psychological 
outcomes in this donor group.
Aims The research programme aims to provide a 
comprehensive assessment of the unspecified donor 
programme in the UK. It aims to identify reasons for 
variations in practice across centres, explore outcomes 
for donors and ascertain barriers and facilitators to 
UKD, as well as assess the economic implications of 
unspecified donation.
Methods The research programme will adopt a 
mixed-methods approach to assessing UKD nationally 
using focus groups, interviews and questionnaires. Two 
study populations will be investigated. The first will 
include transplant professionals involved in unspecified 
kidney donation. The second will include a 5-year 
prospective cohort of individuals who present to any of 
the 23 UK transplant centres as a potential unspecified 
living kidney donor. Physical and psychological 
outcomes will be followed up to 1 year following 
donation or withdrawal from the donation process. A 
matched sample of specified donors (those donating 
to someone they know) will be recruited as a control 
group. Further qualitative work consisting of interviews 
will be performed on a purposive sample of unspecified 
donors from both groups (those who do and do not 
donate).
Dissemination The findings will be reported to NHS 
Blood and Transplant and the British Transplant Society 
with a view to developing national guidelines and a 
protocol for the management of those presenting for 
unspecified donation.
trial registration number ISRCTN23895878, Pre-results.
IntroDuctIon
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Protocol
strengths and limitations of this study
 ► This is a prospective, mixed-methods study using 
both qualitative and quantitative methods to answer 
complex questions regarding barriers to service 
delivery.
 ► This is a widely multi-professional study drawing 
experiences from a variety of fields (surgery, 
medicine, psychology, psychiatry, ethics, NHS Blood 
and Transplant).
 ► This study will assist in the development of national 
guidelines and a protocol in conjunction with NHS 
Blood and Transplant and the British Transplant 
Society.
 ► The study method will capture resource utilisation by 
unspecified donors providing a novel understanding 
of the economic implications of the unspecified 
donation process.
 ► There is a risk of not capturing individuals who 
are disengaged/disappointed in the process of 
unspecified kidney donation.
 ► The study relies on a large number of individuals 
participating and is based on the assumption that 
unspecified donation rates with continue to occur at 
the same rates as prior years.
 ► This study relies on the referrals of donors from 
coordinators across the country, and we may not 
be able to capture every enquiry or expression of 
interest.
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Figure 1 Illustration of an altruistic donor chain, primed by an unspecified kidney donor (UKD).
function post-transplantation. Currently, over one-third 
of all kidney transplants taking place in the UK are from 
living donors. A growing subset of living donors consists 
of individuals who choose to donate a kidney to someone 
that they have not previously met. These are called 
‘unspecified kidney donors’ (UKDs) or ‘non-directed 
altruistic’ donors. Over 500 unspecified donations have 
taken place in the UK since the practice was introduced 
in 2006 and it currently accounts for approximately 11% 
of living donations per year.1
Recipients of living donor kidneys are provided with a 
long-lasting, high-quality organ that is usually sufficient 
to avoid dialysis for an extended period of time.2 Organs 
from UKDs can provide this opportunity for those without 
a living donor, some of whom would have a low chance 
of receiving a deceased donor organ from the waiting 
list due to sensitisation. Additionally, UKD’s organs can 
be further used by introducing them into the National 
Kidney Sharing Scheme. This involves kidney exchanges 
between pairs of donor and recipients who cannot other-
wise proceed due to immunological incompatibility. 
A kidney from a UKD can be used to convert these 
exchanges into a ‘chain’ primed by the UKD (figure 1). 
In this way, the UKD donates to the first recipient, whose 
donor then subsequently donates to another recipient, 
and so on. The chain then terminates with donation to 
an individual on the deceased donor waiting list. In the 
USA, this has resulted in 30 transplants occurring from a 
single UKD.3 In the UK, 47% of UKDs have been used to 
prime short chains of two transplants, and the UK Living 
Donor Strategy aims for 75% to be used for chains, with 
three transplants in each chain, by 20204.
Despite the increase in UKD in the UK, this practice is 
not permittedin many European countries and is uncom-
fortable for some healthcare professionals, principally 
due to concerns about the motivations, characteristics 
and outcomes in this group of donors.5 We have previ-
ously performed the largest quantitative study of psycho-
social and physical outcomes in UKDs, where we sampled 
a national cohort of all 148 UKDs in the UK over the first 
5 years of the programme and compared them with a 
regional sample of 148 specified kidney donors (SKDs, 
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Figure 2 Bound study methodology. NHSBT, NHS Blood and Transplant.
those who donate to someone with whom the donor has 
an existing emotional relationship).6 All donors were sent 
a questionnaire that included a range of validated psycho-
social outcome measures and questions specific to their 
donation. Physical outcome data were obtained from 
the NHS Blood and Transplant (NHSBT). This study 
found that both physical and psychosocial outcomes were 
comparable between UKDs and SKDs, which suggests 
that clinician concerns may be unfounded. The limita-
tions of this study were in its retrospective design and 
the inherent bias associated with this. While we were able 
to analyse physical outcome data for the entire cohort, 
we were unable to determine whether those with poor 
psychosocial outcomes were within the non-responders 
and therefore not captured as part of the study. In addi-
tion, this study demonstrated a broad variation in dona-
tion rates across the country, with no obvious underlying 
reason.
A number of potential deterrents to UKD have been 
highlighted in our previous qualitative work and through 
consultation with UKDs in the development of this study.7 
For example, we have previously found that barriers to 
donation may exist within families where there is tension 
over the decision to donate altruistically and that there 
may be a role for transplant services to support families 
in this situation.7 UKDs have also reported experiencing 
scepticism and resistance from some of the healthcare 
professionals they encountered. The psychiatric assess-
ment (which is no longer legally mandatory but is consid-
ered current best practice) was also described as a difficult 
experience for UKDs who felt that they had to prove their 
sanity.7
AIMs AnD objectIves
The aim of this research programme is to perform a 
comprehensive assessment of the unspecified donor 
programme in the UK. Its objectives are to establish:
1. Whether variation in practice and attitudes across 
the UK is unnecessarily preventing some unspecified 
donation.
2. Whether psychosocial and physical outcomes after 
unspecified donation are equal to those in specified 
donors.
3. The economic benefit of unspecified donation.
Ethical dimensions and implications of unspecified 
donation will also be explored. The programme’s data 
will be used to develop national guidelines and inform 
transplant teams’ decisions about potential donors.
MethoDs AnD AnAlysIs
Design
This is a mixed-methods research programme investi-
gating unspecified kidney donation in the UK over a 
period of 5 years.
research questions
The study will be asking three main questions based on 
the research objectives listed above:
1. RQ1: Is there variation in transplant professionals’ 
(TPs) practice and attitudes, which is preventing 
some unspecified living kidney donations? (Protocol 
in online supplementary file 1)
2. RQ2: Are psychosocial and physical outcomes after 
unspecified donation equivalent to those after spec-
ified donation? (Protocol in  online supplementary 
file 2)
3. RQ3: What is the economic benefit from unspecified 
donation?
In order to answer these three research questions, 
a mixed-methods design will be used, incorporating 
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questionnaires to obtain quantitative data and interviews 
and focus groups to obtain qualitative data (figure 2). 
The third question, related to health economics, will be 
answered using embedded data capture elements within 
the first two research questions.
rQ1 tPs’ Perspective
This substudy defines TP as any healthcare professional 
that may come in contact with a potential unspeci-
fied donor. These include renal transplant physicians, 
surgeons, transplant coordinators, nurses involved in 
transplantation, psychologists and independent asses-
sors, as well as administrative staff from all 23 UK centres. 
Answering this research question will involve three stages. 
The first stage will involve focus groups, led by qual-
itative researchers, in which the views of TPs regarding 
UKD will be ascertained. Focus groups will be under-
taken in four centres, chosen according to their volume 
of donations. This will allow sampling from two centres 
with higher donation rates and two centres whose rates 
are among the lowest. The data obtained will undergo 
thematic analysis, and the key themes identified will be 
extrapolated. This data will be used to inform the subse-
quent stages. The second stage will involve questionnaire 
development, from the themes generated by the focus 
groups. The questionnaires will form the basis of a series 
of prospective cohort studies, which will help ascertain 
broader, nationwide attitudes towards unspecified kidney 
donation, as well as current working practices in the 
different transplant centres. The questionnaires will be 
disseminated using professional networks to all UK TPs. 
The third stage will involve in-depth qualitative interviews 
that will be conducted with TPs selected from six centres, 
again chosen according to their donation volume. These 
interviews will provide a more detailed understanding 
of professionals’ views and will additionally help add 
meaning to the data obtained from the prospective 
cohort studies (questionnaire based).
rQ2 Donors’ Perspective
Two focus groups will be held to assist in informing the 
development of study-specific questionnaires. The first 
focus group will involve individuals that have proceeded 
to donate a kidney as a UKD, while the second will involve 
individuals who presented as potential UKDs, but who did 
not proceed to donate. Themes emerging from the focus 
groups will be identified using thematic analysis, and ques-
tions specific to UKD will be written and validated by the 
research team. These questions will subsequently become 
part of larger questionnaires, which will also include vali-
dated psychosocial outcome measures capturing data 
on a range of different factors.8–17 Validated psychoso-
cial outcomes measures will include: the Client Service 
Receipt Inventory,8 Rosenberg Self-esteem Scale,9 Gener-
alised Anxiety Disorder 7-Item Scale,10 Multi-dimensional 
Scale of Perceived Social Support,11 Ten-Item Person-
ality Measure,12 Decision Regret Scale,13 Patient Health 
Questionnaire (PHQ-9),14 Satisfaction with Life Scale,15 
Flourishing Scale16 and the Quality of Life Health Survey 
(SF-12).17
The questionnaires will be used as part of a longitudinal 
cohort study with four intervention points, as determined 
by participants' progress through the donation pathway. 
All those presenting to a transplant centre as a potential 
UKD will complete a baseline questionnaire. The second 
questionnaire will be given immediately prior to dona-
tion or immediately after the donor is withdrawn from 
the assessment process. The final two questionnaires will 
be given at 3 and 12 months after donation or withdrawal.
The study population will consist of all those individ-
uals approaching a transplant centre with an interest in 
becoming an unspecified donor, irrespective of whether 
they subsequently donated or not. Potential specified 
donors will be used as the control population. Due to the 
fact that not all those who present as potential donors go 
on to donate, the study will result in two test groups and 
two control groups (figure 3).
1. Test group 1: potential unspecified donors who 
proceed to donation.
2. Test group 2: potential unspecified donors who do not 
proceed to donation (either due to personal choice 
or withdrawal by the clinical assessors).
3. Control group 1: potential specified donors who pro-
ceed to donation.
4. Control group 2: potential specified donors who do 
not proceed to donation (either due to personal 
choice or withdrawal by the clinical assessors).
Qualitative interviews will also be completed with a 
sample of 15 UKDs who completed their donation, 15 
UKDs who withdrew and 15 UKDs who were withdrawn 
from the process by the transplant team. Participants will 
be asked about their experience of the donation process 
and services, barriers and enablers to donation and 
outcomes from either donating or withdrawing from the 
process. These interviews will take place 3 months after 
donation or withdrawal from the donation process.
The data collected will be compared with and supple-
mented by each donor’s NHSBT records. These will be 
used to provide physiological outcome data as well as 
information regarding the donation procedure for each 
participant. Physiological data will be collected before 
and after donation, as well as at 12 months following dona-
tion, as per national donor follow-up protocol. NHSBT 
data will be collected retrospectively once a participant 
completes the 12-month questionnaire or earlier should 
they choose to withdraw from the study. Consent to obtain 
NHSBT data will be obtained through the initial study 
participation consent form. A formal request for data use 
has been approved by NHSBT and has been subsequently 
ratified by the Ethics Committee.
rQ3 economic outcomes of unspecified kidney donation
The economic effects of living kidney donation will be 
determined by examining the impact of donation on 
healthcare and societal costs for specified and unspeci-
fied donors, using the Client Service Receipt Inventory 
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Figure 3 Research question 2: participant flow chart. NHSBT, NHS Blood and Transplant.
Figure 4 Study recruitment population.
(CSRI) questionnaire.8 CSRI has been widely used and 
will be adapted and customised to reflect the healthcare 
services used in kidney donation. It will be administered 
in self-reported questionnaires to donors and will aim 
to determine the type and frequency of specific health 
services accessed.
elIgIbIlIty crIterIA
Participants eligible for RQ1 recruitment include any 
TP that has had contact with unspecified donors.
Participants eligible for RQ2 recruitment include any 
individual that makes contact with a transplant centre 
to enquire about unspecified donation and proceeds 
beyond the initial telephone conversation, as well as being 
able to give informed consent. Non-English speakers will 
be included, and adequate translation facilities will be 
provided.
Individuals who have already begun the donation 
work-up process at the time of study commencement will 
also be eligible for recruitment provided they are more 
than 2 weeks away from donation. Control participants 
will be recruited from those individuals known to a trans-
plant centre for the purposes of donating a kidney to 
a known individual (specified donors) using the same 
inclusion criteria. Enrolment can be found in figure 4.
enrolMent
Recruitment to the questionnaire for professionals’ study 
(RQ1) will be through professional networks. Local collab-
orators at specific centres will be established to assist with 
recruitment for the focus groups and interviews.
For the participant study (RQ2), all 23 centres across the 
UK will be set up as participant identification centre sites. 
Any individual who makes contact with a living donor coor-
dinator to enquire about donation will be informed about 
the study and recruitment options. If they are happy to 
receive information and provide verbal consent, the coor-
dinator will either pass their contact details to the research 
team at Guy’s Hospital or will provide the individual with 
the study coordinator’s details. Aggregated data will be 
provided by each centre regarding the total number of 
enquiries made to allow comparison with numbers making 
additional contact and recruited to the study. Once contact 
has been made, the research team from Guy’s Hospital 
will provide further information to the individual and be 
responsible for the recruitment and consent of participants.
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sAMPle sIze cAlculAtIon
Based on previous retrospective work,6 it is expected that 
a recruitment rate of 80% will be achieved. The study will 
aim to recruit 624 participants, of which 224 will go on 
to donate as unspecified donors. This recruitment rate is 
higher than is typical for longitudinal studies but justifi-
able given the population being studied. A sample size of 
624 will provide sufficient precision to estimate the 95% 
CI for proceeding to donation to within ±4% overall and 
to within ±18% for each centre. In summary, the study 
aims to recruit 224 participants who have undergone 
unspecified donation (test group 1) and 400 who did not 
donate (test group 2).
The control group will recruit 200 individuals who are 
donating to friend or relative (specified donors, control 
group 1) and 200 individuals that intend to donate to a 
friend or relative but do not proceed (specified non-do-
nors, control group 2). Based on our retrospective study, 
we expect a recruitment rate of 80%. Therefore, we will 
need to approach 500 specified donors. Given a stable rate 
of approximately 1000 specified donations per year across 
the UK, we anticipate that we will be able to recruit the 
control group using the same 3-year recruitment window 
as the main cohort. If there is no difference between the 
unspecified altruistic and specified donors on the physical 
and psychological variables at 12 months, it will be possible 
to determine that the lower limit of a one-sided 95% CI 
will be above the non-inferiority limit of a standardised 
mean difference of 0.3, which is deemed to be the smallest 
acceptable clinically meaningful difference—this allows for 
20% missing data due to drop-out, at a significance level of 
5% with 90% power.18 These individuals will be recruited 
through transplant coordinators nationally.
stuDy set uP
The research programme will be carried out at a national 
level, with sponsorship and monitoring provided by the 
Guy’s Hospital Research and Development department. 
It has received funding from the National Institute 
of Health Research under Health Services & Delivery 
Research (HS&DR) project number 13/54/54.
Guy and St. Thomas’ NHS Foundation Trust is the lead 
site and are collaborating with Plymouth University, the 
University of Birmingham and King’s College London. 
Twenty-three centres across the UK have been established 
as patient identification centres with all research activity 
being conducted centrally at Guy’s Hospital.
AnAlysIs PlAn
Qualitative data analysis
Data generated via the focus groups and staff interviews 
will be analysed using the framework approach. The frame-
work approach was developed by the National Centre for 
Social Research.19 It is a deductive form of analysis that is 
increasingly being used in healthcare research where the 
aim is to develop practical applications and target policy 
development. It starts deductively from the aims and 
objectives identified in the study. However, this approach 
is grounded and inductive, in that it is heavily based in 
participants’ original accounts and the observations of 
those studied. Framework analysis largely conforms to the 
thematic analysis approach aiming to describe patterns 
in the data and provide a description of the data with an 
emphasis on making the process of identification clear 
and delineated.20 The process of framework analysis 
enables interaction with the data set until a meaningful 
account is revealed with a conceptual framework, thus 
allowing the development to an explanatory account. 
Data will be analysed in adherence with the five stages of 
data analysis using the framework approach as presented 
in Ritchie and Lewis (2003) and aided by the computer 
software programme NVIVO (version 11).
cohort study analysis
In addressing RQ1 concerning variables relating to an 
individual proceeding to donate, descriptive analysis will 
be used to describe the proportion of participants  who 
withdraw or proceed to donation and the reasons for 
failing to proceed. Survival analysis will be used to iden-
tify predictors of proceeding to donation. Specifically, we 
will estimate Cox proportional hazards models where the 
dependent variable is the number of days between first 
contact with the unit and the date of donation, with those 
whose decision has been made censored at the date of 
their last known status. The analysis will include all indi-
viduals enquiring about donation, with the dependent 
variable an indicator for each proceeding to donation. 
Centre-level structural and attitudinal factors identified 
in the study group’s previous work8 will be included in 
the models to determine whether these variables explain 
variation in donation rates. Individual level demo-
graphic variables at baseline (eg, age, sex, education and 
ethnicity) and time-dependent psychological factors will 
be included to determine their association with outcome. 
Power to detect effects for individual level variables will 
be acceptable, but only large effects will be detectable for 
centre level variables.’
To address RQ2 relating to outcomes after donation, 
descriptive analysis will be used to compare baseline 
variables for individuals in each of the specified donor 
(test) and unspecified donor (control) groups. Linear 
or logistic mixed-effects models will be used to estimate 
between group differences in outcome variables at the 
3-month and 12-month postdonation follow-up assess-
ments. A three-level model will be specified with observa-
tions at each time-point (level 1) nested within individuals 
(level 2), who themselves are nested within centres (level 
3). Group membership and follow-up assessment (time) 
will be included in the models as dummy variables. Inter-
action terms for group and time will allow for assess-
ments of differences at individual time points. Models 
will adjust for potential individual level demographic 
confounders measured at baseline (eg, age, sex, educa-
tion and ethnicity) and the baseline level of the outcome 
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variable. Missing outcome data are under the assumption 
that data are missing at random. Sensitivity analysis will be 
performed to assess this assumption.
economic outcomes analysis
The economic benefits of unspecified donation will be 
examined using decision analytical methods. Decision 
analytic models use mathematical relationships to define 
a series of possible consequences that flow from a set of 
alternative options being evaluated. Here the decision is 
to accept or not accept unspecified donation. If unspec-
ified donation is accepted and an individual is assessed, 
then there are a series of events that can occur. These 
include refusal to proceed, being deemed unsuitable, 
successfully donating and a recipient benefiting.
There are costs associated with these, and the outcomes 
will be measured in terms of quality-adjusted life years 
(QALYs) for donors using the SF-12 and for recipients 
with QALYs derived from previous literature.
Data for the model will draw on a systematic litera-
ture review of published economic evaluations of kidney 
donation, as well as from the costing exercise described 
above and expert opinion. The model will take a life-
time horizon (with appropriate discounting) and will 
allow us to estimate the expected costs and QALY gain 
following the start of the process of unspecified donation. 
Given uncertainty around the model parameters, we will 
conduct a series of sensitivity analyses (deterministic and 
probabilistic) to assess its robustness. Key parameters to 
vary may include rejection and refusal rates and values 
placed on future QALY gains. The model will estimate 
costs and benefits for the donors. It will also estimate 
QALY gains for recipients, and if possible, we will incor-
porate future costs for recipients as well.
ethIcs AnD DIsseMInAtIon
The number of individuals considering living kidney 
donation to someone they have not previously met is 
becoming more common and has a significant potential 
to reduce the UK waiting list for kidney transplantation. 
Despite this trend, the concept of unspecified kidney 
donation remains uncomfortable for some clinicians. 
Furthermore, the assessment and donation process may 
have scope for improvement from the donor’s perspec-
tive. This study will provide a comprehensive assessment 
of the unspecified donor programme in the UK in order 
to determine the extent and reasons for variation in 
practice, ascertain barriers to donation, as well as the 
economic implications of unspecified donation. The 
study will also assess clinical outcomes after unspecified 
donation in order to facilitate evidence-based decision 
making regarding future unspecified donors, as well as 
inform the creation of national guidelines.
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